Compare HDB & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HDB | MCK |
|---|---|---|
| Founded | 1994 | 1833 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0B | 98.5B |
| IPO Year | 2002 | 1995 |
| Metric | HDB | MCK |
|---|---|---|
| Price | $23.12 | $877.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $952.92 |
| AVG Volume (30 Days) | ★ 8.6M | 732.9K |
| Earning Date | 04-18-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.53% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | N/A | ★ 5.15 |
| Revenue | N/A | ★ $112,084,000,000.00 |
| Revenue This Year | N/A | $14.94 |
| Revenue Next Year | $14.82 | $8.21 |
| P/E Ratio | ★ $18.92 | $170.79 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $21.77 | $687.68 |
| 52 Week High | $37.45 | $999.00 |
| Indicator | HDB | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 49.16 |
| Support Level | $22.96 | $841.70 |
| Resistance Level | $23.65 | $902.25 |
| Average True Range (ATR) | 0.47 | 18.98 |
| MACD | 0.06 | -4.19 |
| Stochastic Oscillator | 77.79 | 24.60 |
HDFC Bank Ltd company engaged in providing a range of banking and financial services including retail banking, wholesale banking and treasury operations. Its segments are Treasury, Retail banking, Wholesale banking, and Other banking Operations. Majority of incomes if from Retail Banking which consists of digital banking segment which represents business by Digital Banking Units (DBUs) of the Bank. The said DBUs serves retail customers through the Bank's digital network and other online channels; and Non-Digital Banking which serves retail customers through the Bank's branch network and other channels. The bank generates majority of income from Domestic market. Its products are Personal Loan, Car Loan, Business Loan, Two Wheeler Loan, Gold Loan, Home Loan, Pre-Verified Properties, etc.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.